Preclinical News and Research

RSS
New analysis explores importance of medical imaging in drug development, understanding pathological physiology

New analysis explores importance of medical imaging in drug development, understanding pathological physiology

MPI applications: an interview with Tobias Knopp, University Hospital Hamburg

MPI applications: an interview with Tobias Knopp, University Hospital Hamburg

Turnstone announces ongoing enrollment of Marabex clinical trial

Turnstone announces ongoing enrollment of Marabex clinical trial

UTHealth scientist receives $1.9 million from NIH to develop non-antibiotic treatment for C. diff infections

UTHealth scientist receives $1.9 million from NIH to develop non-antibiotic treatment for C. diff infections

Recently-developed drug holds great promise for children with acute lymphoblastic leukaemia

Recently-developed drug holds great promise for children with acute lymphoblastic leukaemia

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

UC San Diego, GSK collaborate to treat leukemia by eliminating cancer stem cells

UC San Diego, GSK collaborate to treat leukemia by eliminating cancer stem cells

News study shows pregnancy complications tied to future cardiovascular disease risk

News study shows pregnancy complications tied to future cardiovascular disease risk

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

NIH-sponsored clinical trial evaluates new investigational vaccine against West Nile Virus infection

NIH-sponsored clinical trial evaluates new investigational vaccine against West Nile Virus infection

Using nanocarriers and microbubbles in drug delivery for treating thrombotic disease

Using nanocarriers and microbubbles in drug delivery for treating thrombotic disease

European Nanomedicine Characterization Lab aims to bring safe, efficient nano-therapeutics to patients

European Nanomedicine Characterization Lab aims to bring safe, efficient nano-therapeutics to patients

Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderate psoriasis

Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderate psoriasis

24% rise in the number of clinical trials according to Cell Therapy Catapult annual UK analysis

24% rise in the number of clinical trials according to Cell Therapy Catapult annual UK analysis

Domainex’s new integrated bioassay service platform accelerates progression of drug discovery projects

Domainex’s new integrated bioassay service platform accelerates progression of drug discovery projects

SWHR co-sponsor Congressional briefing to explore impact of biological sex differences on biomedical research

SWHR co-sponsor Congressional briefing to explore impact of biological sex differences on biomedical research

Prodromal Alzheimer’s phase ‘may span decades’

Prodromal Alzheimer’s phase ‘may span decades’

ASHG declares 2015 recipients of annual Award for Excellence in Human Genetics Education

ASHG declares 2015 recipients of annual Award for Excellence in Human Genetics Education

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.